• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者亲属患精神分裂症的风险:一项荟萃分析。

Risk of schizophrenia in relatives of individuals affected by schizophrenia: A meta-analysis.

作者信息

LE Lo, R Kaur, B Meiser, Mj Green

机构信息

Psychosocial Research Group, Prince of Wales Clinical School, Sydney, NSW, Australia.

Psychosocial Research Group, Prince of Wales Clinical School, Sydney, NSW, Australia.

出版信息

Psychiatry Res. 2020 Feb 5;286:112852. doi: 10.1016/j.psychres.2020.112852.

DOI:10.1016/j.psychres.2020.112852
PMID:32065982
Abstract

A meta-analysis was conducted to estimate schizophrenia incidence in first-degree relatives (FDRs) of probands diagnosed with schizophrenia. The aim was to inform future schizophrenia research and improve accuracy of risk communication to patients. Schizophrenia risk in FDRs with 1 or 2 probands with schizophrenia was investigated by conducting a systematic review of cohort and case-control studies with the following criteria: published between 1977 and 2018; reported odds ratios (OR), relative risk (RR) or sufficient raw data to calculate OR or RR; used appropriate diagnostic criteria; and reported systematic proband recruitment and ascertainment of relatives. Studies were obtained via EMBASE and MEDLINE electronic database searches. From an initial 5755 articles, 19 met the inclusion criteria. Mean effect sizes across studies were estimated using random effects methods. Estimates for schizophrenia risk were OR = 7.69 (95% CI 5.11-11.56) for FDRs of one proband with schizophrenia compared to healthy control probands, increasing to OR = 11.11 (95% CI = 1.45-85.02) for FDRs with two probands with schizophrenia. These findings support the existing literature suggesting significant genetic liability for schizophrenia. The results can be used to educate individuals with a family history of schizophrenia about their risk.

摘要

开展了一项荟萃分析,以估计被诊断为精神分裂症的先证者的一级亲属(FDR)中精神分裂症的发病率。目的是为未来的精神分裂症研究提供信息,并提高向患者进行风险沟通的准确性。通过对队列研究和病例对照研究进行系统评价,调查有1名或2名精神分裂症先证者的FDR患精神分裂症的风险,评价标准如下:发表于1977年至2018年之间;报告了比值比(OR)、相对风险(RR)或有足够的原始数据来计算OR或RR;使用了适当的诊断标准;报告了系统的先证者招募和亲属确定情况。通过EMBASE和MEDLINE电子数据库检索获取研究。从最初的5755篇文章中,有19篇符合纳入标准。使用随机效应方法估计各项研究的平均效应量。与健康对照先证者相比,有1名精神分裂症先证者的FDR患精神分裂症的风险估计值为OR = 7.69(95%CI 5.11 - 11.56),有2名精神分裂症先证者的FDR的该风险估计值增至OR = 11.11(95%CI = 1.45 - 85.02)。这些发现支持了现有文献,表明精神分裂症存在显著的遗传易感性。这些结果可用于对有精神分裂症家族史的个体进行风险教育。

相似文献

1
Risk of schizophrenia in relatives of individuals affected by schizophrenia: A meta-analysis.精神分裂症患者亲属患精神分裂症的风险:一项荟萃分析。
Psychiatry Res. 2020 Feb 5;286:112852. doi: 10.1016/j.psychres.2020.112852.
2
A meta-analysis of the risk of major affective disorder in relatives of individuals affected by major depressive disorder or bipolar disorder.对受重度抑郁症或双相情感障碍影响的个体亲属患重度情感障碍风险的荟萃分析。
J Affect Disord. 2014 Apr;158:37-47. doi: 10.1016/j.jad.2014.01.014. Epub 2014 Feb 5.
3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.与随机试验中评估的医疗保健结果相比,观察性研究设计评估的医疗保健结果。
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):MR000034. doi: 10.1002/14651858.MR000034.pub2.
8
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.一项关于恶性脊柱转移瘤的证据的系统回顾:自然病史和识别高风险椎体骨折和脊髓压迫患者的技术。
Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420.
9
Selective noradrenaline reuptake inhibitors for schizophrenia.用于治疗精神分裂症的选择性去甲肾上腺素再摄取抑制剂。
Cochrane Database Syst Rev. 2018 Jan 25;1(1):CD010219. doi: 10.1002/14651858.CD010219.pub2.
10
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.

引用本文的文献

1
Impact of schizophrenia-associated risk genes on brain functional networks and executive deficits: a study of individuals with schizophrenia and genetic high risk.精神分裂症相关风险基因对脑功能网络及执行功能缺陷的影响:一项针对精神分裂症患者及遗传高危个体的研究
Psychol Med. 2025 Aug 20;55:e240. doi: 10.1017/S0033291725101177.
2
Assessing the quality of life of schizophrenia patients and their family caregivers in a Romanian sample: the role of clinical, sociocultural, and demographic factors.评估罗马尼亚样本中精神分裂症患者及其家庭照顾者的生活质量:临床、社会文化和人口因素的作用。
Med Pharm Rep. 2025 Jan;98(1):96-110. doi: 10.15386/mpr-2816. Epub 2025 Jan 31.
3
Investigation of the Roles of the Adenosine A(2A) and Metabotropic Glutamate Receptor Type 5 (mGlu5) Receptors in Prepulse Inhibition and CREB Signaling in a Heritable Rodent Model of Psychosis.
在一种遗传性啮齿类精神病模型中,对腺苷A(2A)受体和代谢型谷氨酸受体5(mGlu5)受体在预脉冲抑制和CREB信号传导中的作用进行研究。
Cells. 2025 Jan 24;14(3):182. doi: 10.3390/cells14030182.
4
Food addiction and associated factors in newly diagnosed patients with schizophrenia: a cross-sectional comparison with siblings and healthy controls.新诊断精神分裂症患者的食物成瘾及相关因素:与兄弟姐妹和健康对照的横断面比较
J Eat Disord. 2025 Feb 6;13(1):18. doi: 10.1186/s40337-025-01196-z.
5
Theory of mind in schizophrenia through a clinical liability approach: a sib-pair study.通过临床易感性方法研究精神分裂症的心理理论:一项同胞对研究。
Front Psychol. 2024 Dec 13;15:1391646. doi: 10.3389/fpsyg.2024.1391646. eCollection 2024.
6
Transdiagnostic risk of mental disorders in offspring of affected parents: a meta-analysis of family high-risk and registry studies.受影响父母的后代患精神障碍的跨诊断风险:一项针对家庭高危和登记研究的荟萃分析。
World Psychiatry. 2023 Oct;22(3):433-448. doi: 10.1002/wps.21147.
7
A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk.精神分裂症风险潜在神经影像学生物标志物综述
J Psychiatr Brain Sci. 2023;8(2). doi: 10.20900/jpbs.20230005. Epub 2023 May 26.
8
Parental mental disorders and offspring schizotypy in middle childhood: an intergenerational record linkage study.父母的精神障碍与儿童中期子女的精神分裂型特质:一项代际记录关联研究。
Soc Psychiatry Psychiatr Epidemiol. 2023 Nov;58(11):1637-1648. doi: 10.1007/s00127-023-02455-7. Epub 2023 Mar 13.
9
Working memory and sensory memory in subclinical high schizotypy: An avenue for understanding schizophrenia?亚临床高精神分裂症特质个体的工作记忆和感觉记忆:理解精神分裂症的一个途径?
Eur J Neurosci. 2023 May;57(9):1577-1596. doi: 10.1111/ejn.15961. Epub 2023 Mar 22.
10
Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas.超越基因的精神障碍风险与保护因素:循证图谱
World Psychiatry. 2021 Oct;20(3):417-436. doi: 10.1002/wps.20894.